There’s generally little incentive for industry to develop medical devices for children: The pediatric market is small (most children are healthy) and clinical trials are harder to do in children.
“Innovation in medical devices with the potential to improve the health of children and adolescents continues to lag in comparison to those for adults,” says Pedro del Nido, MD, leader of the Boston Pediatric Device Consortium and Chief of Cardiac Surgery at Boston Children’s Hospital.
This week, the Innovation and Digital Health Accelerator (IDHA) at Boston Children’s Hospital and the Boston Pediatric Device Consortium (BPDC) announced a national challenge to try to remedy this problem. The Boston Pediatric Device Strategic Partner Challenge will award up to $50,000 to entrepreneurs and innovators seeking to create novel pediatric medical devices, from a total pool of up to $250,000.
Technologies can be at any stage of development, from concept through launched product, with specific interest in five focus areas: cardiovascular/endovascular, asthma, obesity, sepsis and general pediatrics. The deadline for submissions has been extended to 11:59 p.m. ET on October 20, 2017; winners will be announced in January 2018.
BPDC partners Boston Scientific, CryoLife, Edwards Lifesciences, Health Advances, Johnson & Johnson Innovation, Smithwise and Ximedica are offering mentorship opportunities to challenge winners, such as product manufacturing support, business plan development and partnerships with industry leaders.
The BPDC Challenge is funded in part by the FDA Office of Orphan Products Development.
More information and the Challenge application at www.bostonpdc.org. Deadline: October 20, 2017.